FIELD: medicine.
SUBSTANCE: the present innovation deals with cyclosporin-containing and practically oil-free compositions being of immunosuppressive action. The composition contains a hydrophilic surface-active substance, a lipophilic component, a lipophilic surface-active substance and ethanol. As a hydrophilic surface-active substance this composition contains ether of fatty acid and polyoxyethylene sorbitane and product of either natural or hydrogenised castor oil and ethylenoxide; as a lipophilic component and lipophilic surface-active substance it contains ether of fatty acid and sorbitane. The suggested composition has been designed as a gelatinous capsule with solid covering. The present innovation solves the problem dealing with stability of galena compositions with cyclosporin: at treating with water the composition develops practically stable microemulsion.
EFFECT: higher efficiency of application.
11 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PRELIMINARY PREPARED EMULSION CONCENTRATES CONTAINING CYCLOSPORINE OR MACROLIDE | 1999 |
|
RU2235554C2 |
| N-BENZOYLSTAUROSPORIN-CONTAINING SPONTANEOUSLY DISPERSING COMPOSITIONS | 2000 |
|
RU2266121C2 |
| MICROEMULSION COMPOSITIONS INCLUDING SUBSTANCE P ANTAGONISTS | 2005 |
|
RU2397759C2 |
| NEW PHARMACEUTICAL COMPOSITIONS | 1999 |
|
RU2240121C2 |
| PHARMACEUTICAL COMPOSITION, USING CARBOXYLIC ACID FOR STABILIZING MACROLIDE IN THIS COMPOSITION AND METHOD FOR STABILIZING MACROLIDE | 1995 |
|
RU2292887C2 |
| MICROEMULSION PRECONCENTRATE | 1995 |
|
RU2181054C2 |
| SELF-EMULSIFYING COMPOSITION FOR SCARCELY WATER-SOLUBLE MEDICAMENT | 1999 |
|
RU2257917C2 |
| PHARMACEUTICAL COMPOSITIONS | 2011 |
|
RU2639482C2 |
| PHARMACEUTICAL COMPOSITIONS COMPRISING CAMPTOTHECIN DERIVATIVE | 2012 |
|
RU2620331C2 |
| PHARMACEUTICAL COMPOSITIONS | 1998 |
|
RU2185188C2 |
